100
Participants
Start Date
September 15, 2024
Primary Completion Date
September 15, 2026
Study Completion Date
February 15, 2027
Med-LFD intervention
In the beginning of the intervention, blood and stool samples will be collected. All participants of the group at phase 1 (elimination phase), will initially follow the Med- LFD (2-6 weeks). At phase 2 (reintroduction phase), patients will gradually reintroduce foods rich in FODMAPs (6-8 weeks) and test their tolerance. At phase 3 (maintenance phase), following the reintroduction of foods rich in FODMAPs, patients will follow an individualized diet based on their personal tolerance (a combination of high and low FODMAPs). In the end of intervention, stool samples will be collected again.
RECRUITING
Attikon General University Hospital of Athens, Athens
Attikon Hospital
OTHER